http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-137249-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5386
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5386
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-536
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B05B9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
filingDate 2003-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f8ffeffbf879c5aecd31d88869b3df3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44c0ba1b35750d870e7143f5dd170307
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fa4fe503afdf29b67fda8692474d160
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a3aef9863634db9af07bc1f8b20cf59
publicationDate 2009-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-137249-A
titleOfInvention Aerosol formulation for inhalation containing a tiotropium salt
abstract THE PRESENT INVENTION RELATES TO A PROPELLANT-FREE AEROSOL FORMULATION OF A PHARMACEUTICALLY ACCEPTABLE SALT OF TIOTROPIUM DISSOLVED IN WATER. THE FORMULATION ACCORDING TO THE INVENTION IS PARTICULARLY SUITABLE FOR NEBULISING THE ACTIVE SUBSTANCE USING AN ATOMISER IN ORDER TO ADMINISTER THE ACTIVE SUBSTANCE PREFERABLY TO TREAT THE INDICATIONS ASTHMA AND COPD BY INHALATION.
priorityDate 2002-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448551087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60830

Total number of triples: 35.